Ethiopian Ambassador and Director General FDA inaugurated Cadila Pharma’s new formulation development laboratory yesterday during a high-level Ethiopian delegation’s visit to the company’s state-of-the-art plant in Dholka, according to a company statement.
H E Dr Tizita Mulugeta Yimam, Ambassador Extraordinary and Plenipotentiary of the Federal Democratic Republic of Ethiopia to India, inaugurated the formulation development laboratory along with Heran Gerba, Director General, Ethiopian Food and Drug Administration, Dr HG Koshia, FDCA Commissioner, Gujarat, and other officials, said the statement.
It notified that the ground floor of the formulation development laboratory is focussed on solid orals, the first floor on injections, while the second floor houses the analytical lab.
“It was an interesting visit to Cadila Pharma’s plant and office, and learn more about their work. Cadila has a plant in Ethiopia. We need to work closely to maintain the relationship and to support each other. Ethiopia offers great opportunities for drug companies and for Cadila Pharma to expand its facilities in Ethiopia,” said Yimam in the statement.
The delegation also visited Cadila Pharma’s corporate campus at Bhat, it added.
“The delegation noted and lauded Cadila Pharma’s role in supplying high-quality affordable medicines to patients in Ethiopia and other countries from its plant in Ethiopia, and assured all support and cooperation,” said Biswajit Mitra, Chief Mentoring Officer, Cadila Pharma, in the statement.
Dr Koshia interacted with the delegates and shared details about Gujarat’s significant contribution to the country’s pharma production, concluded the statement.